| 产品详情 |
| Edit |   |
|---|
| Product Name | Apolipoprotein C3, Human Plasma, VLDL |
|---|
| Description | MW: 8750. Purity >95% by SDS-PAGE analysis. Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15 mg per 100 ml. Prepared from fresh, non-frozen plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 |
|---|
| Size | 0.2 mg, 0.5 mg |
|---|
| Concentration | 1.0 mg/ml |
|---|
| Applications | n/a |
|---|
| Other Names | [apolipoprotein C-III; Apolipoprotein C-III; apolipoprotein C-III; apo-CIII; apoC-III; apolipoprotein C3; apolipoprotein C-III; Apolipoprotein C3] |
|---|
| Gene, Accession, CAS # | APOC3; APOC3; HALP2; APOCIII; Apo-CIII; ApoC-III, Gene ID: 345, Accession: NP_000031.1 |
|---|
| Catalog # | MBS135971 |
|---|
| Price | |
|---|
| Order / More Info | Apolipoprotein C3, Human Plasma, VLDL from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|